CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$3.10
Tradestie Score
34
Market Cap
$330.07M
Revenue Growth
-0.6%
Analyst Upside
+145.2%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 35 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.27
|
$341.56M | - | 36 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.94
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$12.92
|
$328.62M | - | 44 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.82
|
$308.74M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$8.42
|
$307.12M | - | 35 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.55
|
$304.12M | - | 49 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$17.89
|
$297.23M | - | 49 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.05
|
$293.03M | - | 57 | Compare |
|
OMER
Omeros Corporation
|
$18.28
|
$281.75M | 11.8 | 41 | Compare |
More CLLS Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry